Speaker illustration

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

John Deanfield is Professor of Cardiology at UCL and Consultant Cardiologist at Barts Heart Centre, London. He is Director of the National Centre for Cardiovascular Prevention and Outcomes and the National Institute for Cardiovascular Outcomes Research. He has chaired numerous Boards e.g. Joint British Societies National Guidelines for Cardiovascular Disease Prevention and with Public Health England, NHS Choices and NHS England led the development of the public Heart Age Tool. He is widely published in leading medical and scientific journals (Papers 468; Citations >104K; H index 131).

The weight of cardiovascular risk: addressing obesity in cardiac patients

Event: ESC Preventive Cardiology 2024

Topic: Obesity

Session type: Satellite Symposium

Thumbnail

Weight loss as a therapeutic target in HFpEF: dawn of a new era?

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Novel weight loss strategies to reduce cardiovascular risk in obesity

Event: ESC Congress 2023

Topic: Obesity

Session type: Satellite Symposium

Thumbnail

Perivascular adipose tissue and coronary heart disease: how significant is the link?

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session type: Symposium

Thumbnail

Obesity and CV disease – Lowering CV risk with novel weight loss strategies

Event: ESC Congress 2022

Topic: Obesity and Diabetes

Session type: Satellite Symposium

Thumbnail

Navigating obesity treatment for prevention of CVD

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Improving cardiovascular risk management in patients with obesity

Event: ESC Congress 2020

Topic: Obesity

Session type: Industry Q&A session

Thumbnail

Managing the burden of cardiovascular disease: time to focus on obesity care (Accredited by EACCME)

Event: ESC Congress 2020

Topic: Obesity

Session type: Industry Q&A session

Thumbnail

Impact of novel guidelines: transforming diabetes management in cardiology

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Transforming diabetes management in cardiology: impact of novel therapies

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb